✨ Health Notices




NEW ZEALAND GAZETTE

No. 57

Health

Medicines Act 1981

Corrigendum

Consent to the Distribution of Changed Medicines

In the notice published in the New Zealand Gazette, 16 May 1996, No. 48, page 1301, notice number 3161, delete the word "sodium" in the 13th line. The name of the active ingredient will then read "ganciclovir".

Dated this 31st day of May 1996.

HUGH BABER, Assistant General Manager, Health Regulation and Protection, pursuant to delegation given by the Minister of Health on the 18th day of January 1996.

g0361/4


Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Lamivudine 150 mg Tablet Glaxo Operations UK Limited, Ware, Hertfordshire, United Kingdom 3TC
Lamivudine 10 mg/mL in 240 mL Oral solution Glaxo Operations UK Limited, Speke, Liverpool, United Kingdom 3TC
Saquinavir mesylate 228.7 mg equivalent to 200 mg saquinavir free base Capsule F Hoffmann-La Roche Limited, Basle, Switzerland Invirase

Note: These provisional consents are valid for 2 years from the date of publication of this notice.

Dated this 30th day of May 1996.

HUGH BABER, Assistant General Manager, Health Regulation and Protection, pursuant to delegation given by the Minister of Health on the 18th day of January 1996.

g0361/2


Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act, and are set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Acetylsalicylic acid 150 mg Tablet Stevens Chem Industries (NZ) Limited, Pakuranga, Auckland Aspec
Benzoyl peroxide 10% w/w in 10 g, 50 g Gel, topical Galderma Laboratories, de Mont Desir, Alby Sur Cheran, France Benzac AC 10 gel
Benzoyl peroxide 2.5% w/w in 10 g, 50 g Gel, topical Galderma Laboratories, de Mont Desir, Alby Sur Cheran, France Benzac AC 2.5 gel
Benzoyl peroxide 5% w/w in 10 g, 50 g Gel, topical Galderma Laboratories, de Mont Desir, Alby Sur Cheran, France Benzac AC 5 gel
Rocuronium bromide 10 mg/mL in 5 mL, 10 mL, 25 mL Solution for injection (vials) Organon International BV., Oss, The Netherlands Esmeron
Somatropin 18IU, 36IU, 72IU equivalent to 6.66 mg, 13.32 mg 26.64 mg respectively plus 3.15 mL of diluent Injection, cartridge and syringe (diluent only) Eli Lilly International Corporation, Indianapolis, Indiana, United States of America and Lilly France SA., Fegersheim, France. Diluent only: Federa Society Co-operative, Brussels, Belgium Humatrope
Somatropin 4IU, 16IU Injection, powder (vial) Eli Lilly International Corporation, Indianapolis, Indiana, United States of America and Lilly France SA., Fegersheim, France Humatrope
Risperidone 1 mg, 2 mg, 3 mg 4 mg Tablets Janssen Cilag SpA., Borgo S. Michele, Latina, Italy and Janssen Pharmaceutica nv., Beerse, Belgium Risperdal
Roxithromycin 50 mg Tablet, dispersible Roussel-Uclaf, Usiphar Production Unit, Compiegne, France Rulide D
Lansoprazole 15 mg, 30 mg Capsules Lederle Laboratories, Cyanamid of Great Britain Limited, Gosport, Hampshire, United Kingdom Zoton

Dated this 30th day of May 1996.

HUGH BABER, Assistant General Manager, Health Regulation and Protection, pursuant to delegation given by the Minister of Health on the 18th day of January 1996.



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1996, No 57


NZLII PDF NZ Gazette 1996, No 57





✨ LLM interpretation of page content

πŸ₯ Corrigendum to Medicines Act 1981 Notice

πŸ₯ Health & Social Welfare
31 May 1996
Medicines Act, Corrigendum, Ganciclovir
  • HUGH BABER, Assistant General Manager, Health Regulation and Protection

πŸ₯ Provisional Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
30 May 1996
Medicines Act, Provisional Consent, Lamivudine, Saquinavir mesylate
  • HUGH BABER, Assistant General Manager, Health Regulation and Protection

πŸ₯ Consent to the Distribution of Changed Medicines

πŸ₯ Health & Social Welfare
30 May 1996
Medicines Act, Changed Medicines, Acetylsalicylic acid, Benzoyl peroxide, Rocuronium bromide, Somatropin, Risperidone, Roxithromycin, Lansoprazole
  • HUGH BABER, Assistant General Manager, Health Regulation and Protection